TRANSACTIONS - CEC CAPITAL

Cancel

Date：2024-02
/index.php?a=shows&catid=34&id=771
On February 21, 2024, Yantai Dongcheng Biochemicals (002675) announced that its wholly-owned subsidiary, Yitai Pharmaceutical, intends to purchase the 99mTc-GSA injection and GSA cold kit (hereinafter referred to as the "target product") held by Rongcheng
Cancel

Date：2024-02
/index.php?a=shows&catid=34&id=770
Today, Affection Animal Pharmaceuticals successfully completed a Series C funding round worth hundreds of millions of yuan. This equity financing was co-led by Yuanxi Haihe Fund and Songqing Shenhui Jiarui Private Investment Fund, with Guohai Innovation C
Cancel

Date：2024-01
/index.php?a=shows&catid=34&id=768
On January 8, 2024, Rokid officially signed the "Lingban Smart Investment Cooperation Agreement" with the Hefei Municipal Government. The two parties will collaborate on the development of the metaverse industry and engage in deep cooperation. Simultaneou
Cancel

Date：2023-11
/index.php?a=shows&catid=34&id=767
This innovative platform specializes in recombinant protein drugs for metabolic diseases. QL Biopharm announces the completion of a nearly 200 million B+ round of financing. IMEIK and China US Green Fund led this financing round, with significant contrib
Cancel

Date：2023-09
/index.php?a=shows&catid=34&id=766
In recent days, leading domestic automotive recycling company Yuan Planet announced the successful completion of B1 and B2 funding rounds, raising millions of dollars. Gobi Partners GBA, Joy Capital, NIO Capital, and other institutions jointly participate
Cancel

Date：2023-09
/index.php?a=shows&catid=34&id=764
Beijing Honest Technology Co., Ltd., which focuses on X-ray acquisition and AI identification technology, Ltd. announced the completion of hundreds of millions of yuan in Series B financing. The round was led by China Venture Capital， Minmetals Innovative Investment, GuoTai JunAn ZhengYu investment and See Fund. CEC Capital acted as Honest's exclusive financial advisor on the transaction.
Cancel

Date：2023-07
/index.php?a=shows&catid=34&id=763
In June, Sinovation, the leading domestic neurosurgery intelligent platform for diagnosis and minimally invasive surgery, announced the completion of a super-billion D+ round financing. The investors in this round include Xinda Kunpeng, TsingVentures, Pea
Cancel

Date：2023-07

Exclusive Financial Advisor to SUNWODA
Cancel

Date：2023-06
/index.php?a=shows&catid=34&id=706
The round was led by New Alliance Capital and Zhangkeherun Venture Capital, with participation from new investors Rockbleu Capital, Royal Fund, Zhuhai Huajin Capital, and Elikon Venture, and continued support from existing investors Delos Global Investmen